viewpoint
By:  Paul S. Koch, M.D.
Banning O.D.s Solves Nothing

at press time
The latest news

street sense - Debate Rages Over "Outsourcing"
By:  Jerry Helzner, Senior Editor
When U.S. companies move jobs to other countries, are they staying competitive or ruining our economy?

rx perspective - The Case for Combination Drugs
By:  Christopher Kent, Senior Associate Editor
Mixed results from clinical trials may underestimate the value of this glaucoma treatment option.

instrument insider
By:  Robert H. Osher, M.D.
The Osher IOL Cutter From Duckworth & Kent

contact lens business - Fostering Success with Multifocals
By:  Christopher Kent, Senior Associate Editor
With effective communication and careful patient selection, these lenses can be a boon to your practice.

spotlight - Nailing Down Progression
By:  Christopher Kent, Senior Associate Editor
An upgrade for the Humphrey Field Analyzer separates developing glaucoma from variability and false positives.

research digest
Summaries of studies presented at the ARVO and ASCRS meetings.

stat tracker
The Latest Data on the Contact Lens Market

marketplace
Focus on Punctum Plugs